(Hurley & Frier, 2025) For patients, this means the first question to ask of any provider offering peptide therapy isn't "do you offer peptides" but "how are you sourcing them and what is the current regulatory status of each compound you prescribe?" A provider still listing Category 2 compounds as standard menu offerings without discussing compounding compliance is telling you something important about their regulatory literacy
These drugs are great for weight loss, but we watch their effect on your hormones
So theres a theoretical link that it could prevent cancers because you wont get aberrant cell growth that might lead to premature death. Improved Cognitive Function For women in midlife experiencing brain fog, Midi's NAD+ Nasal Spray can help restore the mental clarity that used to feel effortless
The two trade names, Ozempic and Wegovy, differ in terms of dosage
Durante los ensayos clnicos de tirzepatide, se reportaron casos de pancreatitis aguda en pacientes tratados con el medicamento, aunque la incidencia fue baja
